Potential benefits of using non coplanar field and intensity modulated radiation therapy to preserve the heart in irradiation of lung tumors in the middle and lower lobes

Radiotherapy and Oncology

Volumn 80, Issue 3, 2006, Pages 333-340

  Chapet, Olivier ^a   Khodri, Mustapha ^a   Jalade, Patrice ^a   N'guyen, Daniel ^a   Flandin, Isabelle ^a   D'hombres, Anne ^a   Romestaing, Pascale ^a   Mornex, Francoise ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Heart; IMRT; Lung; Non coplanar

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ESOPHAGUS; HEART; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG LOBE; LUNG TUMOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIATION DOSE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; HEART; HUMANS; IMAGING, THREE-DIMENSIONAL; LUNG NEOPLASMS; RADIATION DOSAGE; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33748714111     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.07.009     Document Type: Article

References (33)

1. Belderbos J., De Jaeger K., Heemsbergen W., et al. First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy. Radiother Oncol 66 (2003) 119-126
2. Burman C., Kutcher G., Emami B., et al. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 21 (1991) 123-136
3. Chapet O., Thomas E., Kessler M., et al. Esophagus sparing in lung tumor irradiation: an EUD-based optimization technique. Int J Radiat Oncol Biol Phys 63 (2005) 179-187
4. Chapet O., Ten Haken R.K., Kong F., and Hayman J.A. NTCP modeling for acute esophagitis in patients treated with conformal radiation therapy for non small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 60 (2004) S2314
5. Chapet O., Kong F., Quint L., et al. CT-based definition of thoracic lymph node stations: an atlas from the University of Michigan. Int J Radiat Oncol Biol Phys 63 (2005) 170-178
6. Le Chevalier T., Arrigada R., Quoix E., et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small cell lung cancer: first analysis of a randomized trial. J Natl Cancer Inst 83 (1991) 417-423
7. Choy B., and Deasy J.O. The generalized equivalent uniform dose function as a basis for intensity-modulated treatment planning. Phys Med Biol 47 (2002) 3579-3589
8. Choy H., Akerley W., Safran H., et al. Multiinstitutional phase II trial of paclitaxel carboplatin and concurrent radiation therapy for locally advanced non-small cell lung cancer. J Clin Oncol 16 (1998) 3316-3322
9. Graham M., Purdy J.B.E., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non small cell lung cancer. Int J Radiat Oncol Biol Phys 45 (1999) 323-329
10. Grills I., Yan D., Martinez A., et al. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. Int J Radiat Oncol Biol Phys 57 (2003) 875-890
11. Hayman J., Martel M.K., and Ten Haken R.K. Dose escalation in non small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. J Clin Oncol 19 (2001) 127-136
12. Knoos T., Kristensen I., and Nilsson P. Volumetric and dosimetric evaluation of radiation treatment. Int J Radiat Oncol Biol Phys 42 (1998) 1169-1176
13. Komaki R., Lee J.S., Milas L., et al. Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small cell lung cancer: report of a randomized comparative trial. Int J Radiat Oncol Biol Phys 58 (2004) 1369-1377
14. Komaki R., Scott C., Lee J.S., et al. Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06. Am J Clin Oncol 20 (1997) 435-440
15. Kutcher G.J., and Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume model. Int J Radiat Oncol Biol Phys 16 (1989) 1623-1630
16. Lau D., Leigh B., Gandara D., et al. Twice weekly paclitaxel and weekly carboplatin with concurrent thoracic irradiation followed by carboplatin/paclitaxel consolidation for stage III non-small cell lung cancer. A California Cancer Consortium phase II trial. J Clin Oncol 19 (2001) 442-447
17. Lui H., Wang X., Dong L., et al. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 58 (2004) 1268-1279
18. Lyman J.T., and Wolsbarst A. Optimization of radiation therapy, a dose-volume reduction algorithm. Int J Radiat Oncol Biol Phys 17 (1989) 433-436
19. Marks L.B., Munley M., Bentel C., et al. Physical and biological predictors of changes in whole-lung function following thoracic irradiation. Int J Radiat Oncol Biol Phys 39 (1999) 563-570
20. Mountain C., and Dresler C. Regional lymph node classification for lung cancer staging. Chest 111 (1997) 1718-1723
21. Nguyen N., Leonardo J., Karlsson U., et al. Efficacy of combined radiation, paclitaxel and carboplatin for locally advanced non-small cell lung carcinoma. Anticancer Res 23 (2002) 3429-3435
22. Niemerko A. A generalized concept of equivalent uniform dose (EUD). Med Phys 26 (1999) 1100
23. Rosenman J., Halle J., Socinski M., et al. High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small cell lung cancer: technical issues and results of a phase I/II trial. Int J Radiat Oncol Biol Phys 54 (2003) 348-356
24. Rosenzweig K., Mychalczak B., Fuks Z., et al. Final report of the 70.2 and 75.6 Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer. Cancer 6 (2000) 82-87
25. Sakai H., Yoneda S., Kobayashi K., et al. Phase II study of bi-weekly docetaxel and carboplatin with concurrent thoracic radiation therapy followed by consolidation chemotherapy with docetaxel plus carboplatin for stage III unresectable non-small cell lung cancer. Lung Cancer 43 (2004) 195-201
26. Schaake-Koning C., Van De Bogaert W., Dalesio O., et al. Effect of concomitant cisplatinum and radiotherapy on inoperable non-small cell lung cancer. New Engl J Med 326 (1992) 524-530
27. Seppenwoolde Y., Lebesque J., De Jaeger K., et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Int J Radiat Oncol Biol Phys 55 (2003) 724-735
28. Tan E., Wee J., Ang P., et al. Induction chemotherapy followed by concurrent chemoradiotherapy in stage III unresectable non-small cell lung cancer. Acta Oncol 38 (1999) 1005-1009
29. Trodella L., Granone P., Valente S., et al. Phase I gemcitabine and concurrent radiotherapy in patients with inoperable non-small cell lung cancer. J Clin Oncol 20 (2002) 804-810
30. Werner-Wask M., Scott C., Graham Ml., et al. Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivariate analysis of 1076 RTOG patients. Int J Radiat Oncol Biol Phys 44 (1999) 327-331
31. Wu Q., Mohan R., Niemerko A., et al. Optimization of intensity modulated radiotherapy plans based on the equivalent uniform dose. Int J Radiat Oncol Biol Phys 52 (2002)
32. Wu K., Liao Y., Qian H., et al. Three dimensional conformal radiation therapy for non small cell lung cancer: a phase I/II dose escalation clinical trial. Int J Radiat Oncol Biol Phys 57 (2003) 1336-1344
33. Yorke E., Jackson A., Rosenzweig K., et al. Correlation of dosimetric factors and radiation pneumonitis incidence for non-small cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 63 (2005) 672-682